Lisa Maree Williams via Getty Images What to watch at next week's FDA meeting on COVID- vaccines for kids The outcome of a high-stakes advisory panel Tuesday could open the door for millions of kids to receive Pfizer's coronavirus vaccin...
biopharmadive.com was registered 1 decade 1 year ago. It has a alexa rank of #188,534 in the world. It is a domain having .com extension. It is estimated worth of $ 66,000.00 and have a daily income of around $ 110.00. As no active threats were reported recently, biopharmadive.com is SAFE to browse.
Daily Unique Visitors: | 8,836 |
Daily Pageviews: | 44,180 |
Income Per Day: | $ 110.00 |
Estimated Worth: | $ 66,000.00 |
Google Indexed Pages: | Not Applicable |
Yahoo Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Google Backlinks: | Not Applicable |
Bing Backlinks: | Not Applicable |
Alexa BackLinks: | Not Applicable |
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Very Poor |
WOT Privacy: | Very Poor |
WOT Child Safety: | Very Poor |
Alexa Rank: | 188,534 |
PageSpeed Score: | 89 ON 100 |
Domain Authority: | 49 ON 100 |
Bounce Rate: | Not Applicable |
Time On Site: | Not Applicable |
Total Traffic: | 227.53K |
Direct Traffic: | 29.90% |
Referral Traffic: | 9.02% |
Search Traffic: | 51.09% |
Social Traffic: | 8.73% |
Mail Traffic: | 0.78% |
Display Traffic: | 0.48% |
BioPharma Dive, Washington D.C. 14328 likes · 21 talking about this. We provide business journalism and in-depth insight into the most impactful news...
Issue or publication date: BioPharma Dive is a digital-only publication that posts original journalism articles to its website and via an email newsletter ...
View BioPharma Dive (www.biopharmadive.com) location in New York, United States , revenue, industry and description. Find related and similar companies as ...
BioPharma Dive is the mobile friendly industry dashboard for biotech and pharma executives. We curate the industry's most important news,social commentary, ...
New database from BioPharma Dive designed to help you analyze the current boom in biotech IPOs. Emerging biotechs have been setting and breaking records for ...
Use Muck Rack to learn more about BioPharma Dive and connect with journalists at BioPharma Dive.
May 21, 2021 ... Related Publications. BioPharma Dive · MedTech Dive. Follow. Twitter · Facebook · LinkedIn · RSS. Feedback. Work email: * Message: *. S...
Nov 10, 2020 ... Professor Jacob Sherkow was quoted in an industry publication, BioPharma Dive, on what appears to be increased scrutiny from the FDA over ...
Jan 4, 2016 ... The team at Industry Dive is proud to announce the launch of two new weekly editions of BioPharma Dive, BioPharma Dive: Manufacturing and ...
Nov 9, 2020 ... 9 https://www.biopharmadive.com/news/uniqure-hemophilia-b-gene-therapy-hope-trial/589336/. 10 In major surprise, FDA rejects high-profile ...
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development ...
4 days ago ... Picture for Novavax tumbles after report on COVID-19 vaccine production delay. Like Comment Share. biopharmadive.com ...
May 7, 2021 ... Accessed May 7, 2021 at https://www.biopharmadive.com/news/drug-spending-increase-2018-specialty-meds/519001/; Specialty Pharmacy. APHA.
Feb 14, 2020 ... ... firms up policies retrieved on (01/29/2020) from https://www.biopharmadive.com/news/fda-gene-therapy-guidance-sameness-durability/571225 ...
Jul 6, 2021 ... Nontraditional players like technology companies have been eyeing the healthcare sector for some time. They come with deep expertise in ...
Explore our publications: Banking Dive · BioPharma Dive · CFO Dive · CIO Dive · Construction Dive · Cybersecurity Dive · Food Dive ·...
Biogen's Alzheimer's pitch yields few converts - Biopharma Dive Constantine Lyketsos, a psychiatry and behavioral sciences professor at Johns Hopkins ...
Aug 8, 2020 ... move by rival Amgen. BioPharma Dive. February 11, 2019. Available at: https://www.biopharmadive.com/news/regeneron-sanofi-cut-pcsk9-list-.
Aug 3, 2017 ... ... the agency announced it would deny an expanded indication for cognitive dysfunction (http://www.biopharmadive.com/news/in-reversalfda- ...
Sep 22, 2021 ... Related Publications. BioPharma Dive · Healthcare Dive. Follow. Twitter · Facebook · LinkedIn · RSS. Feedback. Work email: * Message: *...
Daiichi spends $300M to settle Benicar suits, Biopharma Dive (08/2017); Update 2-FDA looking into death risk from Daiichi's Benicar, Reuters (06/2011) ...
H1 Headings: | 1 | H2 Headings: | 2 |
H3 Headings: | 39 | H4 Headings: | 4 |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | 1 | Total Images: | 116 |
Google Adsense: | Not Applicable | Google Analytics: | UA-19684343-41 |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
Getty Images | 12 | 0.619 % | No |
via Getty | 10 | 0.516 % | No |
sample Select | 9 | 0.464 % | No |
view sample | 9 | 0.464 % | No |
Select Newsletter | 9 | 0.464 % | No |
UPDATED Oct | 6 | 0.31 % | No |
2021 at | 6 | 0.31 % | No |
Weekly Every | 6 | 0.31 % | No |
gene therapy | 5 | 0.258 % | No |
Deep Dive | 5 | 0.258 % | No |
Gene Therapy | 5 | 0.258 % | No |
BioPharma Dive | 4 | 0.206 % | No |
up to | 4 | 0.206 % | No |
you agree | 4 | 0.206 % | No |
to receive | 4 | 0.206 % | No |
Terms of | 4 | 0.206 % | No |
Images FDA | 4 | 0.206 % | No |
least one | 4 | 0.206 % | No |
View all | 4 | 0.206 % | No |
agree to | 4 | 0.206 % | No |
Words | Occurrences | Density | Possible Spam |
---|---|---|---|
view sample Select Newsletter | 6 | 0.31 % | No |
you agree to our | 4 | 0.206 % | No |
via Getty Images FDA | 4 | 0.206 % | No |
to our Terms of | 3 | 0.155 % | No |
agree to our Terms | 3 | 0.155 % | No |
our Terms of Use | 3 | 0.155 % | No |
of Use and Privacy | 3 | 0.155 % | No |
Use and Privacy Policy | 3 | 0.155 % | No |
newsletter you agree to | 3 | 0.155 % | No |
Terms of Use and | 3 | 0.155 % | No |
our newsletter you agree | 3 | 0.155 % | No |
By signing up to | 3 | 0.155 % | No |
consent By signing up | 3 | 0.155 % | No |
user consent By signing | 3 | 0.155 % | No |
signing up to receive | 3 | 0.155 % | No |
up to receive our | 3 | 0.155 % | No |
receive our newsletter you | 3 | 0.155 % | No |
to receive our newsletter | 3 | 0.155 % | No |
and Privacy Policy You | 3 | 0.155 % | No |
Privacy Policy You can | 3 | 0.155 % | No |
Domain Registrar: | NameCheap, Inc. |
---|---|
Registration Date: | 2013-05-23 1 decade 1 year 5 months ago |
Last Modified: | 2020-11-14 4 years 1 week 11 hours ago |
Host | Type | TTL | Extra |
---|---|---|---|
biopharmadive.com | A | 293 |
IP: 172.67.72.5 |
biopharmadive.com | A | 293 |
IP: 104.26.11.62 |
biopharmadive.com | A | 293 |
IP: 104.26.10.62 |
biopharmadive.com | NS | 86400 |
Target: ivy.ns.cloudflare.com |
biopharmadive.com | NS | 86400 |
Target: sid.ns.cloudflare.com |
biopharmadive.com | SOA | 3600 |
MNAME: ivy.ns.cloudflare.com RNAME: dns.cloudflare.com Serial: 2038651958 Refresh: 10000 Retry: 2400 Expire: 604800 |
biopharmadive.com | MX | 300 |
Priority: 30 Target: aspmx3.googlemail.com |
biopharmadive.com | MX | 300 |
Priority: 10 Target: aspmx.l.google.com |
biopharmadive.com | MX | 300 |
Priority: 20 Target: alt1.aspmx.l.google.com |
biopharmadive.com | MX | 300 |
Priority: 20 Target: alt2.aspmx.l.google.com |
biopharmadive.com | MX | 300 |
Priority: 30 Target: aspmx2.googlemail.com |
biopharmadive.com | TXT | 300 |
TXT: facebook-domain-verification=iz27ygnlm1f tdm5tkc1ib5f1hxz99e |
biopharmadive.com | TXT | 300 |
TXT: google-site-verification=wGWwJv0X5z-YL36 NbGCYh6tdVMq10nkQ5LSnjO1e0Rk |
biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::681a:a3e |
biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::ac43:4805 |
biopharmadive.com | AAAA | 293 |
IPV6: 2606:4700:20::681a:b3e |
1. | marion gruber |
2. | biopharma dive |
3. | apellis |
4. | neuro pharmaceuticals |
5. | gene therapy |
Not Applicable |
1. | inoreader.com |
2. | protopage.com |
3. | thehighwire.com |
4. | demorgen.be |
5. | thezvi.wordpress.com |
1. | investors.biomarin.com |
2. | facebook.com |
3. | alliancerm.org |
4. | amerisourcebergen.com |
5. | resources.industrydive.com |
香港商报是一份历史悠久、发行海内外的商业财经类大报,1952年新中国成立初期即在香港正式创办,至今已有近61年的风雨历程,是香港历史上最为悠久的中文报章之一,被中央政府定位为中国的国际传媒窗口:对外宣传中国,对内报道国外;以商业财经宣传为主,以政治改革报道为辅!
JustLend is the first official lending platform on TRON where users can borrow, lend, deposit assets and earn interests. JustLend是波场网络上的首个官方借贷项目,您可以在其中进行贷款,借出,存储资产并赚取利息。